Tuesday, August 25, 2026 Never miss a recall or a rule change Go Pro · $20/mo →
Inside MedSpa
FDA Recall & Compliance Alerts for Medspa Owners
InjectablesRHA Redensity Eye Wins FDA Nod for Under-Eye HollowstodayMarketGLP-1 Pill Era Is Forcing Beauty Market Shift2 days agoBusiness & M&AGalderma Opens Miami HQ for U.S. and Latin AmericatodayDevices & TechUltherapy PRIME Real-Time Imaging Reshapes Midface Lifting2 days agoDevices & TechMerz Partners with NANOTEC on Aesthetic LongevitytodayInjectablesAEON Releases Expanded ABP-450 Botox Biosimilar Data2 days agoDevices & TechXERF Technology Launches in Sydney for Skin TighteningtodayRegulatoryRevance Wins FDA Nod for Under-Eye Injectables2 days agoRegulatoryAbbVie Launches Phase 2 Forehead Lines StudyyesterdayDevices & TechSofwave Hits One Million Treatments MilestoneyesterdayBusiness & M&AAllergan Aesthetics Overhauls Loyalty ProgramyesterdayBusiness & M&AEvolus Expands Estyme to Canada, Australia, New Zealandyesterday
1 free article left this week. A free account gets you 4 a week.Go Pro →
Business & M&A

Galderma Opens Miami HQ for U.S. and Latin America

Swiss aesthetics giant establishes regional command center, signaling expansion push in Americas.

Image: Inside MedSpa
1-YEAR MOVE
+15% −13%
ABBV ▲11.6%
1-year price move by ticker
TickerCompany1-year change
ABBVAbbVie (Allergan Aesthetics)+11.6%

Galderma has opened a new U.S. and Latin America headquarters in Miami, consolidating regional operations and signaling accelerated investment in the Americas market. The move reflects the company's strategy to deepen penetration in high-growth Latin American territories while strengthening its U.S. commercial footprint.

Miami's location serves as a natural hub for Latin American distribution and regulatory engagement, particularly as Galderma expands its injectables and device portfolios across the region. The headquarters move typically precedes expanded sales force deployment, localized marketing, and faster regulatory navigation for new product launches.

Miami hub positions Galderma for accelerated Latin America expansion.

For U.S. and Latin American practice owners, this infrastructure investment often signals incoming product launches, enhanced rebate programs, and closer sales support—particularly relevant for Galderma's toxin and filler lines competing against AbbVie and Revance.

Source: original report ↗

Free alerts

Free: recall & rule-change alerts for your practice.

Get the recalls and state-law changes that hit your treatment room, in your inbox — free. Unsubscribe in one click.

Free · weekly · unsubscribe anytime. Privacy.

Stay three moves ahead of every practice in your market.

Knowing it happened is table stakes. Inside MedSpa Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.

Get the edge · $20/mo

Join the owners who run ahead of the industry. Cancel anytime, one click.

Share

https://insidemedspa.com/article/galderma-miami-headquarters-us-latam/

Discussion

    Leave a comment

    Comments are reviewed before they appear.
    Inside MedSpa Pro

    By the time it's news, it's too late.

    The rebate cut, the scope-of-practice bill, the competitor opening down the street — it hits your business before the trade press ever covers it. Pro gets you there first: what happened, why it touches your margins, and exactly what to do — at 6 AM, in two minutes.

    Go Pro · $20/mo Never miss a recall or a rule change. Cancel anytime.
    The twice-a-week intelligence brief Go Pro · $20/mo